Aurobindo Pharma News
Aurobindo Pharma
US FDA Issues Warning Letter to Aurobindo Pharma Subsidiary Eugia Pharma: What the Regulatory Action Means
FDA action follows an earlier inspection of Eugia Pharma Specialities’ Unit-I in Telangana, which received four observations and an Official Action Indicated classification